Intravenous busulfan decreases hepatic venoocclusive disease and overall 100-day mortality versus oral busulfan as part of conditioning regimen for autologous and allogeneic stem cell transplantation in children

被引：0
|
作者：
Molina, J. R.
Gonzalez, M.
Verdeguer, A.
Martinez, A.
Badell, I.
Diaz, M. A.
Maldonado, M.
Gonzalez, E.
Munoz, A.
Gomez, P.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S290 / S291
页数：2
相关论文
共 50 条
  • [11] Pharmacokinetics and Safety of Intravenous Busulfan in Children with High Risk Neuroblastoma and Ewing Sarcoma Undergoing Autologous Stem Cell Transplantation using Busulfan based Conditioning Regimen
    Keidar, Hila Rosenfeld
    Efrati, Edna
    Kurnik, Daniel
    Edelman, Sabina
    Tal, Alina
    Broitman, Marcela
    Abu Rizk, Jawad
    Dvir, Rina
    Levin, Dror
    Manisterski, Michal
    Achituv, Sivan
    Elhasid, Ronit
    BONE MARROW TRANSPLANTATION, 2018, 53 : 286 - 286
  • [12] A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia
    Yabe, Miharu
    Sako, Masahiro
    Yabe, Hiromasa
    Osugi, Yuko
    Kurosawa, Hidemitsu
    Nara, Taemi
    Tokuyama, Mika
    Adachi, Souichi
    Kobayashi, Chie
    Yanagimachi, Masakatsu
    Ohtsuka, Yoshitoshi
    Nakazawa, Yozo
    Ogawa, Chitose
    Manabe, Atsushi
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 862 - 867
  • [13] Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation
    Park, Silvia
    Hong, Jung Yong
    Choi, Moon Ki
    Kim, Young Saing
    Lee, Ji Yun
    Lim, Sung Hee
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Kihyun
    BLOOD, 2012, 120 (21)
  • [14] Clinical results of autologous or allogeneic stem cell transplantation following a new intravenous busulfan dosing as part of conditioning regimen in childreen: Early clinical outcomes toxicity and compliance
    Prete, A.
    Castellini, C.
    Fagioli, F.
    Rondelli, R.
    Melchionda, F.
    Morello, W.
    Pession, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 101 - 101
  • [15] The use of intravenous busulfan combined with cyclophosphamide reduces early hepatic toxicity and non-relapse mortality following allogeneic haematopoietic stem cell transplantation compared to oral busulfan-containing regimen
    Jun, H. J.
    Kim, K. H.
    Chang, M. H.
    Yi, S. Y.
    Kim, S. J.
    Jang, J. H.
    Kim, K.
    Kim, W. S.
    Kim, D. H.
    Kim, S. J.
    Kim, W. S.
    Jung, C. W.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S171 - S171
  • [16] Once-daily intravenous busulfan versus oral busulfan in children prior to stem cell transplantation: study of pharmacokinetics and clinical outcomes
    Boelens, J. J.
    Bartelink, I.
    Bredius, R.
    Zwaveling, J.
    Bierings, M.
    Rademaker, K.
    Ververs, T.
    van Kesteren, C.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S12 - S12
  • [17] Once-daily intravenous Busulfan versus oral Busulfan in children prior to stem cell transplantation: Study of pharmacokinetics and clinical outcomes
    Boelens, J. J.
    Bartelink, I.
    Bredius, R.
    Zwaveling, J.
    Bierings, M.
    Rademaker, K.
    Ververs, T.
    Kesteren, C. van
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 58 - 59
  • [18] Single daily dose of intravenous busulfan and melphalan as conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation
    de la Rubia, J.
    Lahuerta, J.
    Gonzalez, J.
    Solano, C.
    Rivas, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S323 - S323
  • [19] Alpha n intravenous busulfan based myeloablative conditioning regimen for allogeneic haematopoietic stem cell transplantation in paediatric ALL patients
    Paisiou, A.
    Peristeri, I.
    Kitra, V.
    Vessalas, G.
    Dimopoulou, M.
    Graphakos, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S103 - S103
  • [20] Comparison Of Intravenous With Oral Busulfan In Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative Conditioning Regimens For Pediatric Acute Leukemia
    Kato, Motohiro
    Takahashi, Yoshiyuki
    Tomizawa, Daisuke
    Okamoto, Yasuhiro
    Inagaki, Jiro
    Koh, Katsuyoshi
    Ogawa, Atsushi
    Okada, Keiko
    Cho, Yuko
    Takita, Junko
    Goto, Hiroaki
    Sakamaki, Hisashi
    Yabe, Hiromasa
    Kawa, Keisei
    Suzuki, Ritsuro
    Kudo, Kazuko
    Kato, Koji
    BLOOD, 2013, 122 (21)
12345